Justices Turn Away Solvay FCA Off-Label Marketing Case
The U.S. Supreme Court on Monday rejected a bid to revisit a decision tossing a whistleblower's False Claims Act case that had accused Solvay Pharmaceuticals of inducing false Medicaid claims through...To view the full article, register now.
Already a subscriber? Click here to view full article